entertainment -WSS

entertainment

author：leisure time 2025-09-02 08:24:00 - browse：23

Monica Bertagnolli -- Health Policy coverage from STAT — Dr. Monica Bertagnolli speaks during a visit from first lady Jill Biden to the University of California San Francisco Helen Diller Family Comprehensive Cancer Center in San Francisco, Friday, Oct. 7, 2022. (AP Photo/Jeff Chiu, Pool) Jeff Chiu/AP

WASHINGTON — Sen. Bernie Sanders (I-Vt.) will hold a confirmation hearing next month for Monica Bertagnolli, President Biden’s nominee to run the National Institutes of Health, he said Friday.

Sanders, whose health committee oversees the confirmation of the NIH nominee, had refused to hold a hearing on Bertagnolli until the Biden administration promised more drug pricing reform.

Newsletters

Sign up for D.C. Diagnosis

An insider's guide to the politics and policies of health care.

Please enter a valid email address. Privacy Policy

HHS announced Friday a deal with Regeneron on the development of the Covid-19 monoclonal antibody. That deal seems to have satisfied Sanders’ demands, though Sanders said the administration must add reasonable pricing provisions to all drugs developed with the help of government funding.

“I welcome the Biden Administration’s announcement today that if Regeneron, through a $326 million contract recently signed with HHS, successfully develops a next generation monoclonal antibody for Covid-19 prevention, the list price of this drug must be equal to or lower than the price in other major countries,” Sanders said in a release.

Sen. Elizabeth Warren (D-Mass.) also had withheld support for Bertagnolli’s nomination until Bertagnolli agreed to Warren’s ethics demands. Bertagnolli agreed to not join the pharmaceutical industry or accept payment from the drug industry, until at least four years after leaving her government position.

Previous article： Cancer drug shortages should be causing more outrage
Next article： Readout Newsletter: Wegovy, dialysis, Humira, Vir, and more

focus

WSS

Finland to offer bird flu vaccine to select groups of people, a possible global first

FTC loses bid to block Novant's North Carolina hospital merger

The Harvard botanist who searched for psychedelics in the Amazon

With competition flaring, obesity drug hits goal in liver disease study

Delfi Diagnostics unveils key aspects of liquid biopsy test for lung cancer

6 phony surgeries that take placebo to the extreme

leisure time

entertainment

Sign up for D.C. Diagnosis

focus

Hepatitis C has a cure — but many Americans still lack access to it

R1 RCM gets $5.8 billion buyout offer from private equity firm

At least 13 dead in Texas as scorching temps continue

UnitedHealth CEO's Medicaid comments send insurer stocks diving

Alkermes shareholders re

The most pressing bird flu mysteries scientists want answered

Bright Health sells Medicare Advantage business to Molina

An outdated Medicare rule harms dementia patients with anxiety

How one medical school became remarkably diverse

Medicare Advantage's lean provider networks lead CMS complaints

hotspot

Fight over Supreme Court dialysis ruling puts kidney patients at risk

FDA approves Moderna’s RSV vaccine, its second licensed product

Congress needs to close a vaccine

Cyberattack on UnitedHealth subsidiary cripples pharmacies, hospitals

STAT readers on older presidents, polypills, Medicare, and more

R1 RCM gets $5.8 billion buyout offer from private equity firm

Wikipedia

entertainment

focus

leisure time